Metropolitan Life Insurance Company (MetLife)’s Achillion Pharmaceuticals ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-35,522
| Closed | -$214K | – | 2600 |
|
|
2019
Q4 | $214K | Sell |
35,522
-13,619
| -28% | -$78.8K | ﹤0.01% | 1873 |
|
|
2019
Q3 | $177K | Hold |
49,141
| – | – | ﹤0.01% | 1956 |
|
|
2019
Q2 | $132K | Buy |
49,141
+4,665
| +10% | +$13.8K | ﹤0.01% | 2165 |
|
|
2019
Q1 | $132K | Buy |
+44,476
| New | +$109K | ﹤0.01% | 2156 |
|
|
2018
Q4 | – | Sell |
-46,206
| Closed | -$170K | – | 2601 |
|
|
2018
Q3 | $170K | Hold |
46,206
| – | – | ﹤0.01% | 2119 |
|
|
2018
Q2 | $131K | Buy |
46,206
+5,193
| +13% | +$17.7K | ﹤0.01% | 2188 |
|
|
2018
Q1 | $152K | Buy |
41,013
+14,868
| +57% | +$48.7K | ﹤0.01% | 2061 |
|
|
2017
Q4 | $75K | Sell |
26,145
-48,380
| -65% | -$176K | ﹤0.01% | 2421 |
|
|
2017
Q3 | $335K | Sell |
74,525
-8,502
| -10% | -$37.7K | ﹤0.01% | 1958 |
|
|
2017
Q2 | $381K | Hold |
83,027
| – | – | ﹤0.01% | 1896 |
|
|
2017
Q1 | $350K | Buy |
83,027
+5,833
| +8% | +$24.2K | ﹤0.01% | 1900 |
|
|
2016
Q4 | $319K | Sell |
77,194
-5,408
| -7% | -$28.7K | ﹤0.01% | 2050 |
|
|
2016
Q3 | $669K | Sell |
82,602
-658
| -0.8% | -$5.59K | ﹤0.01% | 1523 |
|
|
2016
Q2 | $649K | Hold |
83,260
| – | – | ﹤0.01% | 1533 |
|
|
2016
Q1 | $643K | Hold |
83,260
| – | – | ﹤0.01% | 1432 |
|
|
2015
Q4 | $898K | Hold |
83,260
| – | – | 0.01% | 1241 |
|
|
2015
Q3 | $575K | Sell |
83,260
-1,023
| -1% | -$8.33K | ﹤0.01% | 1542 |
|
|
2015
Q2 | $747K | Sell |
84,283
-4,053
| -5% | -$38.3K | 0.01% | 1490 |
|
|
2015
Q1 | $871K | Buy |
88,336
+10,538
| +14% | +$132K | 0.01% | 1278 |
|
|
2014
Q4 | $953K | Hold |
77,798
| – | – | 0.01% | 1342 |
|
|
2014
Q3 | $776K | Sell |
77,798
-848
| -1% | -$7.87K | 0.01% | 1439 |
|
|
2014
Q2 | $595K | Buy |
78,646
+3,553
| +5% | +$14.2K | ﹤0.01% | 1713 |
|
|
2014
Q1 | $247K | Sell |
75,093
-3,060
| -4% | -$10.7K | ﹤0.01% | 2319 |
|
|
2013
Q4 | $259K | Hold |
78,153
| – | – | ﹤0.01% | 2291 |
|
|
2013
Q3 | $566K | Hold |
78,153
| – | – | ﹤0.01% | 1682 |
|
|
2013
Q2 | $639K | Buy |
+78,153
| New | +$597K | 0.01% | 1532 |
|
Metropolitan Life Insurance Company (MetLife)'s ACHN Position: Q1 2020 in Review
Metropolitan Life Insurance Company (MetLife) sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 35,522 shares — an estimated $214K sold.
Metropolitan Life Insurance Company (MetLife) first reported a position in ACHN in Q2 2013 and held it in 26 quarters. The position peaked at $953K in Q4 2014. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.
- Metropolitan Life Insurance Company (MetLife) reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
- Metropolitan Life Insurance Company (MetLife) sold 35,522 Achillion Pharmaceuticals shares in Q1 2020, an estimated $214K.
- Metropolitan Life Insurance Company (MetLife) first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 26 quarters.
- Metropolitan Life Insurance Company (MetLife)'s Achillion Pharmaceuticals position peaked at $953K in Q4 2014.
- 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.
Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2020, filed 15 May 2020.